请输入您要查询的百科知识:

 

词条 Substance-induced psychosis
释义

  1. Signs and symptoms

  2. Substances

     ICD-10  Other 

  3. References

  4. External links

{{Infobox medical condition (new)
| name = Substance-induced psychosis
| image =
| caption =
| pronounce =
| field = Psychiatry
| synonyms = Substance-induced psychotic disorder, drug-induced psychosis, toxic psychosis
| symptoms =
| complications =
| onset =
| duration =
| types =
| causes =
| risks =
| diagnosis =
| differential =
| prevention =
| treatment =
| medication =
| prognosis =
| frequency =
| deaths =
}}

Substance-induced psychosis (commonly known as toxic psychosis) is a form of substance use disorder where psychosis can be attributed to substance use. It is a psychosis that results from the effects of chemicals or drugs, including those produced by the body itself. Various psychoactive substances have been implicated in causing or worsening psychosis in users.

Signs and symptoms

{{Main|Psychosis}}

Psychosis manifests as disorientation, visual hallucinations and/or haptic hallucinations.[1] It is a state in which a person's mental capacity to recognize reality, communicate, and relate to others is impaired, thus interfering with the capacity to deal with life demands. While there are many types of psychosis, substance-induced psychosis can be pinpointed to specific chemicals.[2]

Substances

Psychotic states may occur after using a variety of legal and illegal substances. Usually such states are temporary and reversible, with fluoroquinolone-induced psychosis being a notable exception. Drugs whose use, abuse, or withdrawal are implicated in psychosis include the following:

ICD-10

  • F10.5 alcohol:[3][4][5] Alcohol is a common cause of psychotic disorders or episodes, which may occur through acute intoxication, chronic alcoholism, withdrawal, exacerbation of existing disorders, or acute idiosyncratic reactions.[3] Research has shown that alcohol abuse causes an 8-fold increased risk of psychotic disorders in men and a 3 fold increased risk of psychotic disorders in women.[6][7] While the vast majority of cases are acute and resolve fairly quickly upon treatment and/or abstinence, they can occasionally become chronic and persistent.[3] Alcoholic psychosis is sometimes misdiagnosed as another mental illness such as schizophrenia.[8]
  • F12.5 cannabinoid: Some studies indicate that cannabis may trigger full-blown psychosis.[9] Recent studies have found an increase in risk for psychosis in cannabis users.[10]
  • F13.5 sedatives/hypnotics (barbiturates;[11][12] benzodiazepines[13][14][15]): It is also important to this topic to understand the paradoxical effects of some sedative drugs.[16] Serious complications can occur in conjunction with the use of sedatives creating the opposite effect as to that intended. Malcolm Lader at the Institute of Psychiatry in London estimates the incidence of these adverse reactions at about 5%, even in short-term use of the drugs.[17] The paradoxical reactions may consist of depression, with or without suicidal tendencies, phobias, aggressiveness, violent behavior and symptoms sometimes misdiagnosed as psychosis.[18][19] However, psychosis is more commonly related to the benzodiazepine withdrawal syndrome.[20]
  • F14.5 cocaine[21]
  • F15.5 other stimulants: amphetamines;[22] methamphetamine;[22] methylphenidate.[22] See also stimulant psychosis.
  • F16.5 hallucinogens (LSD and others){{citation needed|date=November 2017}}

The code F11.5 is reserved for opioid-induced psychosis, and F17.5 is reserved for tobacco-induced psychosis, but neither substance is traditionally associated with the induction of psychosis.

The code F15.5 also includes caffeine-induced psychosis, despite not being specifically listed in the DSM-IV. However, there is evidence that caffeine, in extreme acute doses or when severely abused for long periods of time, may induce psychosis.[23][24]

Other

  • Fluoroquinolone drugs, fluoroquinolone use has been linked to serious cases of toxic psychosis that have been reported to be irreversible and permanent, see adverse effects of fluoroquinolones[25][26][27][28][29][30][31][32] The related quinoline derivative mefloquine (Lariam) has also been associated with psychosis.[33][34]
  • some over-the-counter drugs, including:
    • Dextromethorphan (DXM) at high doses.[35][36]
    • Certain antihistamines at high doses.[37][38][39][40]
    • Cold Medications[41] (i.e. containing Phenylpropanolamine, or PPA)
  • prescription drugs:
    • Prednisone and other corticosteroids[42]
    • Isotretinoin[43]
    • Anticholinergic drugs
    • atropine[44][45]
    • scopolamine[46]
    • antidepressants[47]
    • L-dopa[48]
    • antiepileptics[49]
  • antipsychotics, in an idiosyncratic reaction
  • Other illegal drugs (not listed above), including:
    • MDMA (ecstasy)[50]
    • Phencyclidine (PCP)[51]
    • Ketamine
  • Synthetic research chemicals used recreationally, including:
    • JWH-018 and some other synthetic cannabinoids, or mixtures containing them (e.g. "Spice", "Kronic", "MNG" or "Mr. Nice Guy", "Relaxinol", etc.).[52] Various "JWH-XXX" compounds in "Spice" or "Incense" have also been found and have been found to cause psychosis in some people.[53][54][55]
    • Mephedrone and related amphetamine-like drugs sold as "bath salts" or "plant food".[56]
  • Plants
    • Hawaiian baby woodrose (contains ergine)
    • Morning glory seeds (contains ergine)
    • Jimson weed[57] (Datura, angel's trumpet, thorn apple)
    • Belladonna (deadly nightshade)
    • Salvia divinorum[58]
  • Volatile solvents and gases (inhalants)
    • Toluene,[59][60] found in glue, paint, thinner, etc. See also toluene toxicity.
    • Butane[61]
    • Gasoline (petrol)[62]

References

1. ^{{cite journal |title=The Dilemma of the Toxic Psychosis: Differential Diagnosis and the PCP Psychosis |last1=Pitts |first1=Ferris N |last2=Allen |first2=Robert E |last3=Aniline |first3=Orm |last4=Burgoyne |first4=Rodney W |journal=Psychiatric Annals |volume=12 |issue=8 |date=August 1982 |pages=762–8 |oclc=5584879101 |doi=10.3928/0048-5713-19820801-07 }}
2. ^http://medical-dictionary.thefreedictionary.com/toxic+psychosis{{full citation needed|date=February 2016}}
3. ^{{EMedicine|article|289848|Alcohol-Related Psychosis}}
4. ^{{Cite journal|last=Soyka |first=Michael |date=March 1990 |title=Psychopathological characteristics in alcohol hallucinosis and paranoid schizophrenia |journal=Acta Psychiatrica Scandinavica |volume=81 |issue=3 |pages=255–9 | pmid = 2343749 |doi=10.1111/j.1600-0447.1990.tb06491.x}}
5. ^{{EMedicine|article|166032|Delirium Tremens (DTs)}}
6. ^{{Cite journal|vauthors=Tien AY, Anthony JC |title=Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences |journal=J. Nerv. Ment. Dis. |volume=178 |issue=8 |pages=473–80 |date=August 1990 |pmid=2380692 |doi= 10.1097/00005053-199017880-00001|url=}}
7. ^{{Cite journal|author=Cargiulo T |title=Understanding the health impact of alcohol dependence |journal=Am J Health Syst Pharm |volume=64 |issue=5 Suppl 3 |pages=S5–11 |date=March 2007 |pmid=17322182 |doi=10.2146/ajhp060647 |url=}}
8. ^{{Cite journal|author=Schuckit MA |title=Alcoholism and other psychiatric disorders |journal=Hosp Community Psychiatry |volume=34 |issue=11 |pages=1022–7 |date=November 1983 |pmid=6642446 |doi= 10.1176/ps.34.11.1022|url=}}
9. ^{{Cite journal|author=Degenhardt L |title=The link between cannabis use and psychosis: furthering the debate |journal=Psychological Medicine |volume=33 |issue=1 |pages=3–6 |date=January 2003 |pmid=12537030 |doi=10.1017/S0033291702007080}}
10. ^{{Cite journal |vauthors=Moore TH, Zammit S, Lingford-Hughes A, etal |title=Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review |journal=Lancet |volume=370 |issue=9584 |pages=319–28 |date=July 2007 |pmid=17662880 |doi=10.1016/S0140-6736(07)61162-3|url=http://orca.cf.ac.uk/619/1/Appendix%201%20%28search%20strategy%29%20Cannabis%20use%20and%20risk%20of%20developing%20psychotic%20or%20affective%20mental%20health%20outcomes%20a%20systematic%20review.pdf }}
11. ^{{Cite journal |vauthors=de Paola L, Mäder MJ, Germiniani FM, etal |title=Bizarre behavior during intracarotid sodium amytal testing (Wada test): are they predictable? |journal=Arquivos de Neuro-Psiquiatria |volume=62 |issue=2B |pages=444–8 |date=June 2004 |pmid=15273841 |doi=10.1590/S0004-282X2004000300012}}
12. ^{{Cite journal|vauthors=Sarrecchia C, Sordillo P, Conte G, Rocchi G |title=[Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication] |language=Italian |journal=Annali Italiani di Medicina Interna |volume=13 |issue=4 |pages=237–9 |year=1998 |pmid=10349206}}
13. ^{{Cite journal|vauthors=White MC, Silverman JJ, Harbison JW |title=Psychosis associated with clonazepam therapy for blepharospasm |journal=The Journal of Nervous and Mental Disease |volume=170 |issue=2 |pages=117–9 |date=February 1982 |pmid=7057171 |doi=10.1097/00005053-198202000-00010}}
14. ^{{Cite journal|vauthors=Jaffe R, Gibson E |title=Clonazepam withdrawal psychosis |journal=Journal of Clinical Psychopharmacology |volume=6 |issue=3 |pages=193 |date=June 1986 |pmid=3711371 |doi=10.1097/00004714-198606000-00021}}
15. ^{{Cite journal|vauthors=Hallberg RJ, Lessler K, Kane FJ |title=Korsakoff-Like Psychosis Associated With Benzodiazepine Overdosage |journal=The American Journal of Psychiatry |volume=121 |issue= 2|pages=188–9 |date=August 1964 |pmid=14194223 |url=http://ajp.psychiatryonline.org/article.aspx?Volume=121&page=188&journalID=13 |doi=10.1176/ajp.121.2.188}}
16. ^{{Cite journal|vauthors=Hall RC, Zisook S |title=Paradoxical reactions to benzodiazepines |journal=British Journal of Clinical Pharmacology |volume=11 |issue= Suppl 1|pages=99S–104S |year=1981 |pmid=6133541 |pmc=1401636|doi=10.1111/j.1365-2125.1981.tb01844.x}}
17. ^{{cite journal |vauthors=Lader M, Morton S | year = 1991 | title = Benzodiazepine Problems | url = | journal = British Journal of Addiction | volume = 86 | issue = 7| pages = 823–828 | doi=10.1111/j.1360-0443.1991.tb01831.x}}
18. ^Benzodiazepines: Paradoxical Reactions & Long-Term Side-Effects
19. ^{{cite journal |vauthors=Hansson O, Tonnby B | year = 1976 | title = Serious Psychological Symptoms Caused by Clonazepam | url = | journal = Läkartidningen | volume = 73 | issue = | pages = 1210–1211 }}
20. ^{{Cite journal|author=Pétursson H |title=The benzodiazepine withdrawal syndrome |journal=Addiction |volume=89 |issue=11 |pages=1455–9 |date=November 1994 |pmid=7841856 |doi=10.1111/j.1360-0443.1994.tb03743.x}}
21. ^{{Cite journal|last=Brady |first=K. T. |author2=R. B. Lydiard |author3=R. Malcolm |author4=J. C. Ballenger |date=December 1991 |title=Cocaine-induced psychosis |journal=Journal of Clinical Psychiatry |volume=52 |issue=12 |pages=509–512 | pmid = 1752853}}
22. ^Diaz, Jaime. How Drugs Influence Behavior. Englewood Cliffs: Prentice Hall, 1996.
23. ^{{Cite journal|vauthors=Hedges DW, Woon FL, Hoopes SP |title=Caffeine-induced psychosis |journal=CNS Spectrums |volume=14 |issue=3 |pages=127–9 |date=March 2009 |pmid=19407709|doi=10.1017/S1092852900020101 }}
24. ^{{Cite journal|vauthors=Cerimele JM, Stern AP, Jutras-Aswad D |title=Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia |journal=The American Journal of Psychiatry |volume=167 |issue=3 |pages=353 |date=March 2010 |pmid=20194494 |doi=10.1176/appi.ajp.2009.09101456}}
25. ^{{Cite journal| author =Cohen JS |date=December 2001 | title =Peripheral Neuropathy Associated with Fluoroquinolones | journal =Ann Pharmacother | volume =35 | issue =12 | pages =1540–7 | pmid =11793615 | url =http://fqvictims.org/fqvictims/News/neuropathy/Neuropathy.pdf | doi =10.1345/aph.1Z429 }}
26. ^{{Cite journal |vauthors=Adams M, Tavakoli H |title=Gatifloxacin-induced hallucinations in a 19-year-old man |journal=Psychosomatics |volume=47 |issue=4 |pages=360 |year=2006 |pmid=16844899 |doi=10.1176/appi.psy.47.4.360 |url=http://psy.psychiatryonline.org/cgi/content/full/47/4/360 |deadurl=yes |archiveurl=https://archive.is/20120722214034/http://psy.psychiatryonline.org/cgi/content/full/47/4/360 |archivedate=2012-07-22 |df= }}
27. ^{{Cite journal|vauthors=Mulhall JP, Bergmann LS |title=Ciprofloxacin-induced acute psychosis |journal=Urology |volume=46 |issue=1 |pages=102–3 |date=July 1995 |pmid=7604468 |doi=10.1016/S0090-4295(99)80171-X |url=http://linkinghub.elsevier.com/retrieve/pii/S0090-4295(99)80171-X}}
28. ^{{Cite journal|author=Reeves RR |title=Ciprofloxacin-induced psychosis |journal=Ann Pharmacother |volume=26 |issue=7–8 |pages=930–1 |year=1992 |pmid=1504404 |doi= 10.1177/106002809202600716 }}
29. ^{{Cite journal|vauthors=Yasuda H, Yoshida A, Masuda Y, Fukayama M, Kita Y, Inamatsu T |title=[Levofloxacin-induced neurological adverse effects such as convulsion, involuntary movement (tremor, myoclonus and chorea like), visual hallucination in two elderly patients] |language=Japanese |journal=Nippon Ronen Igakkai Zasshi |volume=36 |issue=3 |pages=213–7 |date=March 1999 |pmid=10388331 |doi= 10.3143/geriatrics.36.213|url=}}
30. ^{{Cite journal|vauthors=Azar S, Ramjiani A, Van Gerpen JA |title=Ciprofloxacin-induced chorea |journal=Mov. Disord. |volume=20 |issue=4 |pages=513–4; author reply 514 |date=April 2005 |pmid=15739219 |doi=10.1002/mds.20425}}
31. ^{{Cite journal|vauthors=Kukushkin ML, Igonkina SI, Guskova TA |title=Mechanisms of pefloxacin-induced pain |journal=Bull. Exp. Biol. Med. |volume=137 |issue=4 |pages=336–8 |date=April 2004 |pmid=15452594 |doi= 10.1023/B:BEBM.0000035122.45148.93|url=}}
32. ^{{Cite journal |vauthors=Christie MJ, Wong K, Ting RH, Tam PY, Sikaneta TG |title=Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure |journal=Ann Pharmacother |volume=39 |issue=5 |pages=953–5 |date=May 2005 |pmid=15827068 |doi=10.1345/aph.1E587 |url=http://www.theannals.com/cgi/pmidlookup?view=long&pmid=15827068 |archive-url=https://archive.is/20130111103748/http://www.theannals.com/cgi/pmidlookup?view=long&pmid=15827068 |dead-url=yes |archive-date=2013-01-11 }}
33. ^{{Cite journal|vauthors=Marsepoil T, Petithory J, Faucher JM, Ho P, Viriot E, Benaiche F |title=[Encephalopathy and memory disorders during treatments with mefloquine] |language=French |journal=Rev Med Interne |volume=14 |issue=8 |pages=788–91 |year=1993 |pmid=8191092 |doi= 10.1016/S0248-8663(05)81426-2|url=}}
34. ^{{Cite journal|vauthors=Phillips-Howard PA, ter Kuile FO |title=CNS adverse events associated with antimalarial agents. Fact or fiction? |journal=Drug Saf |volume=12 |issue=6 |pages=370–83 |date=June 1995 |pmid=8527012 |doi= 10.2165/00002018-199512060-00003|url=}}
35. ^{{Cite journal|doi=10.1176/appi.ajp.157.2.304 |last = Price | first = L. H. |author2=Lebel, J. | year = 2000 | title = Dextromethorphan-Induced Psychosis | journal = American Journal of Psychiatry | volume = 157 | issue = 2 | pages = 304 | url = http://ajp.psychiatryonline.org/cgi/content/full/157/2/304 | pmid = 10671422 }}
36. ^{{ cite journal | url = http://www.primarypsychiatry.com/aspx/articledetail.aspx?articleid=953 | title = Deciphering a Psychosis: A Case of Dextromethorphan-Induced Symptoms | author = Lachover, L. | journal = Primary Psychiatry | year = 2007 | volume = 14 | issue = 1 | pages = 70–72 }}
37. ^{{Cite journal | doi = 10.1016/S0735-6757(97)90212-6 |author1=Sexton, J. D. |author2=Pronchik, D. J. | title = Diphenhydramine-induced psychosis with therapeutic doses | journal = The American Journal of Emergency Medicine | volume = 15 | issue = 5 | pages = 548–549 | year = 1997 | pmid = 9270406 }}
38. ^{{Cite journal | last = Lang | first = K. |author2=Sigusch, H. |author3=Müller, S. | year = 1995 |trans-title=An anticholinergic syndrome with hallucinatory psychosis after diphenhydramine poisoning | language = German | journal = Deutsche Medizinische Wochenschrift | volume = 120 | issue = 49 | pages = 1695–1698 | pmid = 7497894 | doi = 10.1055/s-2008-1055530 | title = Anticholinergisches Syndrom mit halluzinatorischer Psychose nach Diphenhydramin-Intoxikation }}
39. ^{{Cite journal | last=Schreiber | first = W. |author2=Pauls, A. M. |author3=Krieg, J. C. | year = 1988 |trans-title=Toxic psychosis as an acute manifestation of diphenhydramine poisoning | language = German | journal = Deutsche Medizinische Wochenschrift | volume = 113 | issue = 5 | pages = 180–183 | pmid = 3338401 | doi = 10.1055/s-2008-1067616 | title=Toxische Psychose als Akutmanifestation der Diphenhydraminvergiftung }}
40. ^{{Cite journal | last = Timnak | first = C. |author2=Gleason, O. | year = 2004 | title = Promethazine-Induced Psychosis in a 16-Year-Old Girl | journal = Psychosomatics | volume = 45 | issue = 1 | pages = 89–90 | pmid = 14709767 | doi = 10.1176/appi.psy.45.1.89 }}
41. ^{{ cite journal | url = http://pediatrics.aappublications.org/cgi/content/full/108/3/e52 | journal = Pediatrics | volume = 108 | issue = 3 | year = 2001 | page = e52 | doi = 10.1542/peds.108.3.e52 | title = Toxicity of Over-the-Counter Cough and Cold Medications | last1 = Gunn | first1 = V. L. | last2 = Taha | first2 = S. H. | last3 = Liebelt | first3 = E. L. | last4 = Serwint | first4 = J. R. | citeseerx = 10.1.1.536.6102 }}
42. ^{{Cite journal| pmid = 438794| year = 1979| last1 = Hall | first1 = R. C.| last2 = Popkin| last3 = Stickney| last4 = Gardner| title = Presentation of the steroid psychoses| volume = 167| issue = 4| pages = 229–236| journal = The Journal of Nervous and Mental Disease| doi = 10.1097/00005053-197904000-00006 | first2 = M. K. | first3 = S. K. | first4 = E. R.}}
43. ^{{cite journal |author1=Hull P. R. |author2=D'Arcy C. | year = 2003 | title = Isotretinoin Use and Subsequent Depression and Suicide: Presenting the Evidence | url = | journal = American Journal of Clinical Dermatology | volume = 4 | issue = 7| pages = 493–505 | doi=10.2165/00128071-200304070-00005|pmid=12814338 }}
44. ^{{Cite journal | last = Bergman | first = K. R. |author2=Pearson, C. |author3=Waltz, G. W. |author4=Evans R. III | title = Atropine-induced psychosis. An unusual complication of therapy with inhaled atropine sulfate | journal = Chest | year = 1980 | volume = 78 | issue = 6 | pages = 891–893 | pmid = 7449475 | doi = 10.1378/chest.78.6.891 }}
45. ^{{Cite journal | last = Varghese | first = S. |author2=Vettath, N. |author3=Iyer, K. |author4=Puliyel, J. M. |author5=Puliyel, M. M. | title = Ocular atropine induced psychosis--is there a direct access route to the brain? | journal = Journal of the Association of Physicians of India | year = 1990 | volume = 38 | issue = 6 | pages = 444–445 | pmid = 2384469 }}
46. ^{{Cite journal | last = Barak | first = Segev |author2=Weiner, I. | title = Scopolamine Induces Disruption of Latent Inhibition Which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor | journal = Neuropsychopharmacology | year = 2006 | volume = 32 | issue = 5 | pages = 989–999 | doi = 10.1038/sj.npp.1301208 | pmid = 16971898 }}
47. ^{{cite journal | author = Ellison Gaylord | year = 1995 | title = The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias | url = | journal = Brain Research Reviews | volume = 20 | issue = 2| pages = 250–267 | doi = 10.1016/0165-0173(94)00014-G | pmid=7795658}}
48. ^{{ cite journal |author1=Carey, R. J. |author2=Pinheiro-Carrera, M. |author3=Dai, H. |author4=Tomaz, C. |author5=Huston, J. P. | title = l-DOPA and psychosis: Evidence for l-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone | journal = Biological Psychiatry | year = 1995 | volume = 38 | issue = 10 | pages = 669–676 | doi = 10.1016/0006-3223(94)00378-5 | pmid = 8555378 }}
49. ^{{ cite journal | author = Ettinger, A. B. | title = Psychotropic effects of antiepileptic drugs | journal = Neurology | year = 2006 | volume = 67 | issue = 11 | pages = 1916–1925 | doi = 10.1212/01.wnl.0000247045.85646.c0 | pmid = 17159095 }}
50. ^http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=526 'Ecstasy' Psychosis and Flashbacks F.J. CREIGHTON, D. L. BLACK and C. E. HYDE
51. ^http://www.minddisorders.com/Py-Z/Substance-induced-psychotic-disorder.html Substance-induced psychotic disorder
52. ^http://www.airforcetimes.com/news/2011/06/air-force-spice-users-risk-psychosis-says-doctor-061111w/ Spice users risk psychosis, doctor says By Gidget Fuentes - Staff writerAccessed 06-25-2011
53. ^{{Cite journal|date=2016-07-05|title=Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study|url=http://www.psychiatrist.com/jcp/article/Pages/2016/aheadofprint/15m09938.aspx|journal=The Journal of Clinical Psychiatry|language=English|volume=77|issue=8|pages=e989–e995|doi=10.4088/JCP.15m09938|issn=0160-6689|last1=Shalit|first1=Nadav|last2=Barzilay|first2=Ran|last3=Shoval|first3=Gal|last4=Shlosberg|first4=Dan|last5=Mor|first5=Nofar|last6=Zweigenhaft|first6=Nofar|last7=Weizman|first7=Abraham|last8=Krivoy|first8=Amir|pmid=27379411}}
54. ^{{cite journal | author = Every-Palmer S | year = 2010 | title = Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals | url = | journal = Addiction | volume = 105 | issue = 10| pages = 1859–60 | doi = 10.1111/j.1360-0443.2010.03119.x | pmid = 20840203 }}
55. ^{{cite journal |vauthors=Müller H, etal | year = 2010 | title = The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes | url = | journal = Schizophr. Res. | volume = 118 | issue = 1–3| pages = 309–10 | doi = 10.1016/j.schres.2009.12.001 | pmid = 20056392 }}
56. ^https://www.addictions.com/bath-salts/ Bath Salt Addiction, Accessed 06-25-2011
57. ^{{Cite journal |last=Kurzbaum |first=Alberto |author2=Claudia Simsolo |author3=Ludmilla Kvasha |author4=Arnon Blum |date=July 2001 |title=Toxic Delirium due to Datura Stramonium |journal=Israel Medical Association Journal |volume=3 |issue=7 |pages=538–539 |pmid=11791426 |url=http://www.ima.org.il/imaj/ar01jul-16.pdf |accessdate=2006-10-17 |deadurl=yes |archiveurl=https://web.archive.org/web/20070614091335/http://www.ima.org.il/imaj/ar01jul-16.pdf |archivedate=2007-06-14 |df= }}
58. ^{{Cite journal |doi=10.1176/appi.ajp.2009.08121759 |last=Przekop |first=Peter |author2=Timothy Lee |date=July 2009 |title=Persistent Psychosis Associated With Salvia Divinorum Use |pages=832 |journal=American Journal of Psychiatry|volume=166 |issue=832|url=http://ajp.psychiatryonline.org/cgi/content/full/166/7/832 |accessdate=2010-05-14 |pmid=19570943 }}
59. ^{{Cite journal|last=Tarsh |first=M.J. |year=1979 |title=Schizophreniform Psychosis caused by Sniffing Toluene|journal=Journal of the Society for Occupational Medicine |volume=1979 |issue=29 |pages=131–133 |url=http://occmed.oxfordjournals.org/cgi/reprint/29/4/131.pdf |accessdate=2010-05-14|doi=10.1093/occmed/29.4.131}}
60. ^{{Cite journal|doi=10.4103/0019-5545.58307 |last=Rao |first=Naren P. |author2=Arun Gupta |author3=K. Sreejayan |author4=Prabhat K. Chand |author5=Vivek Benegal |author6=Pratima Murthy |year=2009 |title=Toluene associated schizophrenia-like psychosis|journal=Indian Journal of Psychiatry|volume=51 |issue=4 |pages=329–330 | pmid = 20048466 |pmc=2802388}}
61. ^{{Cite journal|vauthors=Jung IK, Lee HJ, Cho BH |title=Persistent psychotic disorder in an adolescent with a past history of butane gas dependence |journal=European Psychiatry |volume=19 |issue=8 |pages=519–20 |date=December 2004 |pmid=15589716 |doi=10.1016/j.eurpsy.2004.09.010}}
62. ^{{Cite journal|last=Hernandez-Avila |first=Carlos A. |author2=Hector A. Ortega-Soto |author3=Antonio Jasso |author4=Cecilia A. Hasfura-Buenaga |author5=Henry R. Kranzler |year=1998 |title=Treatment of Inhalant-Induced Psychotic Disorder With Carbamazepine Versus Haloperidol|journal=Psychiatric Services|volume=49 |issue=6 |pages=812–815 |pmid=9634163 |doi=10.1176/ps.49.6.812}}

External links

{{Medical resources
| DiseasesDB =
| ICD10 = {{ICD10|F|10||f|10}}.5-{{ICD10|F|19||f|10}}.5
| ICD9 = {{ICD9|292.1}}
| OMIM =
| MedlinePlus =
| ICDO =
| eMedicineSubj =
| eMedicineTopic =
| MeshID = D011605
}}{{Psychoactive substance use}}{{DEFAULTSORT:Substance-Induced Psychosis}}

2 : Psychosis|Psychiatric diagnosis

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/30 4:23:54